| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |